Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.

Leukemia - 1 Dec 2022

Garcia-Gisbert Nieves, Arenillas Leonor, Roman-Bravo David, Rodriguez-Sevilla Juan Jose, Fernández-Rodríguez Concepción, Garcia-Avila Sara, Velez Patricia, Gibert Joan, Fernández-Ibarrondo Lierni, Salar Antonio, Florensa Lourdes, Bellosillo Beatriz, Ferrer Ana, Calvo Xavier

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Lymphocytic Leukemia Research
Share to Dioxygenases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA-Binding Proteins

Share to Leukemia, Myelomonocytic, Chronic

Share to Leukemia, Myelomonocytic, Juvenile

Share to Lymphoma Diagnosis and Treatment

Share to Mutation

Source

Identifiers

PMID: 36273104
DOI: 10.1038/s41375-022-01733-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.PMID 36273104Read ↗

A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.Semantic proximity Read ↗

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevanceSemantic proximity Read ↗

Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.Semantic proximity Read ↗

Comorbidities and mutations including single- and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia-A population-based study.Semantic proximity Read ↗

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevanceSemantic proximity Read ↗

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.Semantic proximity Read ↗

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AMLSemantic proximity Read ↗

Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasiaSemantic proximity Read ↗

TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.Semantic proximity Read ↗

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.Semantic proximity Read ↗

Ten-Eleven-Translocation Genes in Cancer.Semantic proximity Read ↗

Landscape of TET2 Mutations: From Hematological Malignancies to Solid TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.